Calcinose cutanée dans la sclérodermie systémique cutanée limitée : cas clinique et revue des options thérapeutiques
Résumé
Texte intégral :
PDFRéférences
Chander S, Gordon P. Soft tissue and subcutaneous calcification in connective tissue diseases. Curr Opin Rheumatol 2012; 24: 158-1642. Valenzuela A, Song P, Chung L. Calcinosis in scleroderma. Curr Opin Rheumatol. 2018; 30(6): 554-5613. Boulman N, Slobodin G, Rozenbaum M, Rosner I. Calcinosis in rheumatic diseases. Semin Arthritis Rheum 2005; 34: 805-8124. Hsu V, Varga J, Schlesinger N. Calcinosis in scleroderma made crystal clear. Curr Opin Rheumatol. 2019; 31(6): 589-5945. Hsu VM, Emge T, Schlesinger N. X-ray diffraction analysis of spontaneously draining calcinosis in scleroderma patients. Scand J Rheumatol. 2017; 46(2): 118-1216. Nurşen Düzgün. Cutaneous calcinosis in a patient with limited scleroderma: CREST Syndrome. Eur J Rheumatol. 2017 Dec; 4(4): 305-3067. Herrick AL, Gallas A. Systemic-sclerosisrelated calcinosis. J Scleroderma Relat Disord 2016; 1: 177-2408. Valenzuela A, Chung L. Calcinosis: pathophysiology and management. Curr Opin Rheumatol. 2015; 27(6): 542-5489. Pai S, Hsu V. Are there risk factors for scleroderma-related calcinosis? Mod Rheumatol. 2018 May; 28(3): 518-52210. Palmieri GM, Sebes JI, Aelion JA et al. Treatment of calcinosis with diltiazem. Arthritis Rheum 1995; 38: 1646-165411. Dolan AL, Kassimos D, Gibson T, Kingsley GH. Diltiazem induces remission of calcinosis in scleroderma. Br J Rheumatol 1995; 34: 576-57812. Farah MJ, Palmieri GM, Sebes JI et al. The effect of diltiazem on calcinosis in a patient with the CREST syndrome. Arthritis Rheum 1990; 33: 1287-129313. Goossens J, Courbebaisse M, Caudron E et al. Efficacy of intralesional sodium thiosulfate injections for disabling tumoral calcinosis: two cases. Semin Arthritis Rheum 2017; 47: 451-45514. Baumgartner-Nielsen J, Olesen AB. Treatment of skin calcifications with intralesional injection of sodium thiosulphate: a case series. Acta Derm Venereol 2016; 96: 257-25815. Bienvenu B. Traitement des calcinoses sous-cutanées des connectivites. Rev Med Interne. 2014 ; 35(7) : 444-45216. Sparsa A, Lesaux N, Kessler E et al. Treatment of cutaneous calcinosis in CREST syndrome by extracorporeal shock wave litho-tripsy. J Am Acad Dermatol. 2005; 53(5) (Suppl 1): S263-S26517. de Paula DR, Klem FB, Lorencetti PG et al. Rituximab-induced regression of CREST-related calcinosis. Clin Rheumatol 2013; 32: 281-28318. Cukierman T, Elinav E, Korem M, Chajek-Shaul T. Low dose warfarin treatment for calcinosis in patients with systemic sclerosis. Ann Rheum Dis 2004; 63: 1341-134319. Tosounidou S, MacDonald H, Situnayake D. Successful treatment of calcinosis with infliximab in a patient with systemic sclerosis/myositis overlap syndrome. Rheumatology (Oxford) 2014; 53: 960-96120. Schanz S, Ulmer A, Fierlbeck G. Response of dystrophic calcification to intravenous immunoglobulin. Arch Dermatol. 2008; 144: 585-587
Renvois
- Il n'y a présentement aucun renvoi.